Frequency and Prognosis of JAK2 V617F, Calr, MPL and ASXL1 Mutations in Primary Myelofibrosis

被引：0

作者：

Sorigue, Marc ^{[1
]}

Cabezon, Marta ^{[2
]}

Garcia, Olga ^{[1
]}

Velez, Patricia ^{[3
]}

Marce, Silvia ^{[2
]}

Boque, Concha ^{[3
]}

Xicoy, Blanca ^{[1
]}

Fernandez, Cristalina ^{[4
]}

Xandri, Marisol ^{[2
]}

Casanova, Enric ^{[3
]}

Gallardo, David ^{[4
]}

Milla, Fuensanta ^{[2
]}

Ribera, Josep-Maria ^{[2
]}

Feliu, Evarist ^{[2
]}

Zamora, Lurdes ^{[2
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, ICO, Josep Carreras Leukemia Res Inst, Badalona, Spain

[2] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, ICO Badalona, Josep Carreras Leukemia Res Inst, Badalona, Spain

[3] Hosp Duran y Reynals, ICO, Lhospitalet De Llobregat, Spain

[4] Hosp Josep Trueta, ICO, Girona, Spain

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis.
Barosi, Giovanni
Poletto, Valentina
Massa, Margherita
Campanelli, Rita
Villani, Laura
Bonetti, Elisa
Viarengo, Gianluca
Catarsi, Paolo
Klersy, Catherine
Rosti, Vittorio
BLOOD, 2012, 120 (21)
[32] Blast transformation in a patient with primary myelofibrosis initiated from JAK2 V617F progenitor
Swierczek, Sabina I.
Yoon, Donghoon
Prchal, Josef T.
BLOOD, 2007, 110 (11) : 240B - 240B
[33] THE JAK2 46/1 (GGCC) HAPLOTYPE IS ASSOCIATED WITH PRIMARY MYELOFIBROSIS INDEPENDENTLY OF V617F MUTATIONAL STATUS, DISEASE CHARACTERISTICS OR PROGNOSIS
Vannucchi, M.
Guglielmelli, P.
Biamonte, F.
Spolverini, A.
Pancrazzi, A.
Pieri, L.
Isgro, A.
Antonioli, E.
Bartalucci, N.
Bosi, A.
Barosi, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 471 - 471
[34] DOES ALLELE BURDEN IMPORT IN MYELOFIBROSIS WITH JAK2 V617F MUTATION?
Maria Isabel, Montero Cuadrado
Francisco Jose, Marquez Malaver
Cruz Estrella, Carrillo
Canale Silvia, Garcia
Lucia, Mezquita
Javier, Delgado
Caro Rocio, Marin
Francisco Jose, Martin Dominguez
Nancy, Rodriguez
Campos Jose, Gonzalez
Jose Francisco, Falantes
Jose Antonio, Perez Simon
HAEMATOLOGICA, 2021, 106 (10) : 258 - 258
[35] Spectrum of CALR, MPL and cKIT Driver Mutations in Non-BCR/JAK2 V617F Myeloproliferative Neoplasm in Major Tertiary Hospital Pakistan
Ahmed, Zeeshan A. A. Ansar
Naz, Samra
Ujala, Anum
Islam, Naznee
Ali, Natasha
JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (06): : S27 - S27
[36] Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations
Makarik, Tatiana, V
Abdullaev, Adhamjon O.
Nikulina, Elena E.
Treglazova, Svetlana A.
Stepanova, Elena E.
Subortseva, Irina N.
Kovrigina, Alla M.
Melikyan, Anait L.
Kulikov, Sergei M.
Sudarikov, Andrey B.
GENES, 2021, 12 (04)
[37] Clinicopathologic Spectrum of Co-existing JAK2 V617F and ASXL1 Mutation in Myeloproliferative Neoplasms: A Single Institute Experience
Talibi, Sami
Ferreira-Gonzalez, Andrea
Jayakumar, Rajeswari
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1024 - 1024
[38] ESSENTIAL THROMBOCYTHEMIA WITH JAK2 V617F OR CALR MUTATION: TWO DIFFERENT PHENOTYPES
Vilches Moreno, A. S.
Guerrero Fernandez, L.
Gonzalez Medina, J.
Ayala Diaz, R.
Martinez Lopez, J.
Monteagudo Saiz, D.
Andreu Costa, M. A.
Robles Marinas, V.
HAEMATOLOGICA, 2016, 101 : 811 - 811
[39] Clinicopathologic Spectrum of Co-existing JAK2 V617F and ASXL1 Mutation in Myeloproliferative Neoplasms: A Single Institute Experience
Talibi, Sami
Ferreira-Gonzalez, Andrea
Jayakumar, Rajeswari
MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1024 - 1024
[40] Detection and interpretation of low level JAK2 V617F mutations
Bryon, Jane
Akiki, S.
Griffiths, M.
JOURNAL OF MEDICAL GENETICS, 2012, 49 : S46 - S46

← 1 2 3 4 5 →